KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

House of Commons Science and Technology Committee launches inquiry into impact of EU regulation & policy on UK life sciences

The Science and Technology Committee have launched an inquiry into the impact of EU regulation and policy on the UK life sciences. The inquiry will look at how EU legislation and regulation can best facilitate, and avoid impeding, collaboration and innovation in the life sciences with particular reference to the UK life sciences sector.

Nicola Blackwood MP, Chair of the Science & Technology Committee said:

“The UK has a thriving and world-leading life sciences sector that delivers huge economic benefits.  Given the global market place in which our life science industries compete, regulations made at the European Union level can exert considerable influence. Safeguards are essential, but we need to ensure that EU regulations help rather than hinder research and innovation in the life sciences. Focus on these issues will undoubtedly sharpen as we approach the referendum on UK membership of the European Union.”

Background

The UK life sciences industry has been one of the most successful globally. Spanning medical devices, medical diagnostics and pharmaceuticals, through to synthetic and industrial biotechnology industry, the life science sector is high-tech, research-intensive, innovative and highly diverse. Data from the Bioscience and Health Technology Database shows that, in 2014, the UK life science sector consisted of almost 5,000 companies employing 183,000 people and generating over £56 billion of turnover from sales into the UK and overseas. In December 2011, the Prime Minister launched the ‘Strategy for UK life sciences’ and this was subsequently incorporated in the Government’s Industrial Strategy in 2012. The Strategy stresses that the UK is “Europe’s leading destination for inward investment in the sector”.

EU legislation and regulation holds the potential to facilitate collaboration and innovation across the 28 member states through harmonising the procedures under which research, and the commercialisation of that research, is conducted. It is not currently clear, however, if such benefits are being fully realised or whether other factors, such as overly prohibitive regulations or the inconsistent application of those regulations across the EU, are limiting UK innovation in the life science sector. As the Government seeks to "renegotiate the United Kingdom’s relationship with the European Union and pursue reform of the European Union for the benefit of all member states", as well as reduce the "burden of excessive EU regulation" the Science and Technology Committee wishes to examine more closely the impact of EU regulation and policy on the UK life sciences sector.

The Committee welcomes submissions by 4 March 2016 on the following issues:

• What are the key EU regulations and frameworks that govern/influence the conduct of research and innovation in the UK life sciences?

• In what ways do these EU regulations affect the UK life sciences? What are their benefits and the drawbacks?

• How transparent, consultative and evidence-based are EU policy-making processes?

• To what extent is the UK able to shape regulatory processes at the EU level that affect the life sciences?

• Is the UK able to depart from the application, standards or timing of such EU regulation?

Submit written evidence and more information.